*From the Authors*:

We thank Dr. Liu and Dr. Zhou for their interest and thoughtful comments about our cross-sectional study of sex steroid hormones and asthma among adult participants in the National Health and Nutrition Examination Survey (NHANES) ([@bib1]). We reported that elevated serum levels of free testosterone were associated with lower odds of current asthma in women. After stratification by obesity, we found that elevated serum levels of both free testosterone and estradiol were associated with lower odds of current asthma in obese women and that an elevated serum estradiol level was associated with lower odds of current asthma in nonobese men ([@bib1]).

Dr. Liu and Dr. Zhou questioned why we excluded participants ≥80 years of age from the analysis. This decision was made because we lacked the exact ages of those subjects (e.g., data from a 91-yr-old participant was clustered in the same category as those from an 80-yr-old participant) and because of high potential for comorbidities that could be misclassified as asthma in elderly subjects (e.g., heart failure).

We acknowledged having lower statistical power to detect an association between sex hormones and asthma in men than in women. Dr. Liu and Dr. Zhou suggested an analysis including subjects with missing data for covariates and accounting for the time of the day (morning, afternoon, or evening) and the season (November--April or May--October) of collection of blood samples, as testosterone level may vary according to these variables. According to NHANES analytical guidelines ([@bib2]), mobile examination center operations avoid certain geographic areas during the winter. Thus, the statistical efficiency of the sample is diminished for any variable that may be related to seasonal variation and differs by region of the country ([@bib2]). In an effort to address the concerns outlined here, we repeated the analysis after assigning an "unknown" category for missing data on categorical covariates (e.g., ever use of sex hormones in women) and a median value for missing data on continuous covariates. This multivariable analysis, which included all 9,238 eligible participants, yielded very similar results to those reported in our recent article ([Table 1](#tbl1){ref-type="table"}).

###### 

Multivariable Analysis of Sex Hormone Levels and Current Asthma by Sex (*n* = 9,238)

                                                          Odds Ratio (95% Confidence Interval)                                                                                   
  ----------------------------- ----------------------------------------------------------------------------------------- ------------------------------------------------------ ------------------------------------------------------
  Men (*n* = 4,502)                                                                                                                                                                                         
   Free testosterone (pmol/L)                                                                                                                                                                               
    Q1 (\<137.8)                                                     1.0 (reference)                                                               ---                                              1.0 (reference)
    Q2 (137.8--197.1)                                               0.96 (0.61--1.52)                                                              ---                                             1.04 (0.67--1.60)
    Q3 (197.1--263.7)                                               0.65 (0.40--1.07)                                                              ---                                             0.72 (0.46--1.12)
    Q4 (≥263.7)                                                     0.97 (0.47--1.94)                                                              ---                                             1.11 (0.60--2.06)
   Estradiol (pmol/L)                                                                                                                                                                                       
    Q1 (\<68.3)                                                            ---                                                               1.0 (reference)                                        1.0 (reference)
    Q2 (68.3--87.2)                                                        ---                                                              0.68 (0.38--1.21)                                      0.68 (0.39--1.17)
    Q3 (87.2--108.6)                                                       ---                                                              0.71 (0.42--1.21)                                      0.71 (0.45--1.12)
    Q4 (≥108.6)                                                            ---                                                              0.74 (0.44--1.26)                                      0.73 (0.48--1.13)
  Women (*n* = 4,736)                                                                                                                                                                                       
   Free testosterone (pmol/L)                                                                                                                                                                               
    Q1 (\<3.2)                                                       1.0 (reference)                                                               ---                                              1.0 (reference)
    Q2 (3.2--5.6)                                 0.71 (0.52--0.95)[^†^](#tblfn2){ref-type="table-fn"}                                             ---                            0.71 (0.53--0.96)[^†^](#tblfn2){ref-type="table-fn"}
    Q3 (5.6--9.3)                                                   0.85 (0.64--1.12)                                                              ---                                             0.85 (0.63--1.15)
    Q4 (≥9.3)                    0.55 (0.39--0.78)[^‡^](#tblfn3){ref-type="table-fn"}[^§^](#tblfn4){ref-type="table-fn"}                           ---                            0.57 (0.40--0.80)[^‡^](#tblfn3){ref-type="table-fn"}
   Estradiol (pmol/L)                                                                                                                                                                                       
    Q1 (\<22.8)                                                            ---                                                                     1.0                                                    1.0
    Q2 (22.8--87.7)                                                        ---                                                              0.86 (0.55--1.34)                                      0.94 (0.59--1.49)
    Q3 (87.7--307.5)                                                       ---                                             0.67 (0.48--0.94)[^†^](#tblfn2){ref-type="table-fn"}                    0.75 (0.54--1.05)
    Q4 (≥307.5)                                                            ---                                                              0.86 (0.54--1.35)                                      0.97 (0.60--1.57)

*Definition of abbreviation*: Q = quartile.

All models adjusted for age, race/ethnicity, annual household income, body mass index, family history of asthma, secondhand smoke, smoking status, pack-years of smoking, ever use of birth control pills or any sex hormones (in women), the 6-month period of the examination, and the time of day when the examination was performed.

Model 1 assessed free testosterone without adjusting for estradiol, model 2 assessed estradiol without adjusting for free testosterone, and model 3 adjusted for a given other sex hormone.

*P* \< 0.05.

*P* \< 0.01.

*P* for trend \< 0.05.

Finally, we appreciate Dr. Liu and Dr. Zhou's comment on our definition of menopause. We used the mean age at menopause in U.S. women (51 yr) to define menopause. Indeed, average estradiol levels dropped markedly after age 50 years among women included in our analysis. In a secondary analysis, we did not find a significant interaction between menopause (as defined here) and serum estradiol on asthma in participating women. Given the comments by Dr. Liu and Dr. Zhou, we repeated the secondary analysis redefining menopause as not having had a menstrual period for at least a year (\[age when interviewed/examined\] -- \[self-reported age at the last menstrual period\] ≥1 yr) or self-report of having had a hysterectomy in which both ovaries were removed. Using this alternative definition, we also found no significant interaction between menopause and serum estradiol on current asthma.

Large longitudinal studies with precise information on menopausal status should help better understand the relation between sex hormones and current asthma in adults.
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